Study on Single Nucleotide Polymorphisms of Functional Proteins determining Absorption, Metabolism, and Excretion of Edoxaban.
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation
- Focus Pharmacodynamics; Pharmacogenomic
- 27 Oct 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.
- 04 Oct 2017 New trial record